maj 17, 2024 0 12 CELEX:62022TJ0471: Judgment of the General Court (Fifth Chamber) of 15 May 2024.#Issam Anbouba v Council of the European Union.#Case T-471/22.
december 12, 2024 0 11 CELEX:62022TJ0471_INF: Judgment of the General Court (Fifth Chamber) of 15 May 2024.#Issam Anbouba v Council of the European Union.#Case T-471/22.
september 14, 2023 0 38 CELEX:62022TJ0473: Judgment of the General Court (Sixth Chamber) of 13 September 2023.#Gürok Turizm ve Madencilik Anonim Sirketi v European Union Intellectual Property Office.#Case T-473/22.
november 25, 2023 0 20 CELEX:62022TJ0473_INF: Judgment of the General Court (Sixth Chamber) of 13 September 2023.#Gürok Turizm ve Madencilik Anonim Sirketi v European Union Intellectual Property Office.#Case T-473/22.
maj 18, 2023 0 63 CELEX:62022TJ0480: Judgment of the General Court (Seventh Chamber) of 17 May 2023.#Panicongelados-Massas Congeladas, SA v European Union Intellectual Property Office.#Case T-480/22.
avgust 28, 2023 0 47 CELEX:62022TJ0480_INF: Judgment of the General Court (Seventh Chamber) of 17 May 2023.#Panicongelados-Massas Congeladas, SA v European Union Intellectual Property Office.#Case T-480/22.
september 24, 2025 0 0 CELEX:62022TJ0483: Judgment of the General Court (Fifth Chamber, Extended Composition) of 24 September 2025.#Sanofi BV, anciennement Genzyme Europe BV v European Commission.#Public health – Medicinal products for human use – Marketing authorisation for the medicinal product Nexviadyme (avalglucosidase alfa) – Non-recognition of avalglucosidase alfa as a new active substance – Directive 2001/83/EC – Regulation (EC) No 726/2004 – Commission document ‘Notice to Applicants, Volume 2A, Procedures for marketing authorisation, Chapter 1, Marketing Authorisation’ – Standard of proof – Obligation to state reasons – Principle of good administration – Right to be heard – Decision to remove the medicinal product from the European Union Register of Orphan Medicinal Products – Regulation (EC) No 141/200
september 24, 2025 0 0 CELEX:62022TJ0483_RES: Judgment of the General Court (Fifth Chamber, Extended Composition) of 24 September 2025.#Sanofi BV, anciennement Genzyme Europe BV v European Commission.#Public health – Medicinal products for human use – Marketing authorisation for the medicinal product Nexviadyme (avalglucosidase alfa) – Non-recognition of avalglucosidase alfa as a new active substance – Directive 2001/83/EC – Regulation (EC) No 726/2004 – Commission document ‘Notice to Applicants, Volume 2A, Procedures for marketing authorisation, Chapter 1, Marketing Authorisation’ – Standard of proof – Obligation to state reasons – Principle of good administration – Right to be heard – Decision to remove the medicinal product from the European Union Register of Orphan Medicinal Products – Regulation (EC) No 141
november 22, 2023 0 0 CELEX:62022TJ0484: Arrêt du Tribunal (dixième chambre) du 22 novembre 2023 (Extraits).#QN contre Agence de l'Union européenne pour la gestion opérationnelle des systèmes d’information à grande échelle au sein de l’espace de liberté, de sécurité et de justice.#Fonction publique – Agents temporaires – Reclassement – Exercice de reclassement 2021 – Décision de non-reclassement – Taux multiplicateurs de référence – Dispositions générales d’exécution de l’article 54 du RAA – Exception d’illégalité – Égalité de traitement – Responsabilité.#Affaire T-484/22. This document does not exist in English.
julij 27, 2024 0 0 CELEX:62022TJ0484_RES: Judgment of the General Court (Tenth Chamber) of 22 November 2023 (Extracts).#QN v European Union Agency for the Operational Management of Large-Scale IT Systems in the Area of Freedom, Security and Justice.#Civil service – Temporary staff – Reclassification – 2021 reclassification exercise – Decision not to reclassify – Guiding multiplication rates – General provisions for the implementation of Article 54 of the CEOS – Plea of illegality – Equal treatment – Liability.#Case T-484/22.